Michael Magers serves as Executive at Cardium Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Michael Magers has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 31, 2007 involved transacting 15,263 shares valued at $0.
Michael Magers currently holds 104,121 shares of Cardium Therapeutics, Inc. (CDTP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Magers has been a net neutral trader of CDTP stock. They have purchased $0 and sold $0 worth of shares.
Michael Magers's most recent insider trade was on Oct 31, 2007, when they sold 15,263 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |